JP2016540504A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540504A5
JP2016540504A5 JP2016533109A JP2016533109A JP2016540504A5 JP 2016540504 A5 JP2016540504 A5 JP 2016540504A5 JP 2016533109 A JP2016533109 A JP 2016533109A JP 2016533109 A JP2016533109 A JP 2016533109A JP 2016540504 A5 JP2016540504 A5 JP 2016540504A5
Authority
JP
Japan
Prior art keywords
antibody
chain variable
variable region
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533109A
Other languages
English (en)
Japanese (ja)
Other versions
JP6535668B2 (ja
JP2016540504A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/067957 external-priority patent/WO2015084736A2/en
Publication of JP2016540504A publication Critical patent/JP2016540504A/ja
Publication of JP2016540504A5 publication Critical patent/JP2016540504A5/ja
Application granted granted Critical
Publication of JP6535668B2 publication Critical patent/JP6535668B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533109A 2013-12-03 2014-12-01 B細胞受容体複合体膜結合IgMを標的とする抗体およびその使用 Active JP6535668B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361911186P 2013-12-03 2013-12-03
US61/911,186 2013-12-03
PCT/US2014/067957 WO2015084736A2 (en) 2013-12-03 2014-12-01 Antibodies targeting b-cell receptor complex membrane bound igm and uses thereof

Publications (3)

Publication Number Publication Date
JP2016540504A JP2016540504A (ja) 2016-12-28
JP2016540504A5 true JP2016540504A5 (enExample) 2018-01-18
JP6535668B2 JP6535668B2 (ja) 2019-06-26

Family

ID=53274268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533109A Active JP6535668B2 (ja) 2013-12-03 2014-12-01 B細胞受容体複合体膜結合IgMを標的とする抗体およびその使用

Country Status (9)

Country Link
US (2) US9926381B2 (enExample)
EP (1) EP3077010B1 (enExample)
JP (1) JP6535668B2 (enExample)
CN (1) CN106456809B (enExample)
AU (2) AU2014357450B2 (enExample)
CA (1) CA2931779C (enExample)
IL (1) IL245880B (enExample)
SG (1) SG10201709164UA (enExample)
WO (1) WO2015084736A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127827A1 (de) * 2018-12-20 2020-06-25 Ava Lifescience Gmbh Verfahren zur selektion biologischer bindemoleküle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004005A1 (en) 1989-09-15 1991-04-04 Akzo N.V. Compartmentalized container for a plurality of small articles
ATE148348T1 (de) * 1989-09-15 1997-02-15 Tanox Biosystems Inc Behandlung von einer autoimmun-krankheit
CA2624081C (en) * 2005-09-29 2014-09-16 Medimmune, Inc. Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
EP2021027A4 (en) * 2006-05-03 2010-01-27 Guthrie Foundation For Educati IMMUNOGLOBULIN-ASSOCIATED CELL-SURFACE DETERMINANTS IN THE TREATMENT OF B-CELL DISEASES
WO2008027986A2 (en) * 2006-09-01 2008-03-06 Therapeutic Human Polyclonals, Inc. Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
CN101965363A (zh) * 2006-11-02 2011-02-02 丹尼尔·J·卡鹏 具有活动部分的杂合免疫球蛋白
EP1972640A1 (en) * 2007-03-23 2008-09-24 Biomay AG Apoptosis inducing antibodies
WO2011064758A2 (en) * 2009-11-30 2011-06-03 Pfizer Limited Fusion protein
US9540657B2 (en) * 2012-05-25 2017-01-10 California Institute Of Technology Expression of secreted and cell-surface polypeptides

Similar Documents

Publication Publication Date Title
JP2020504101A5 (enExample)
JP2019201643A5 (enExample)
JP2020510422A5 (enExample)
JP2018521638A5 (enExample)
JP2012116856A5 (enExample)
JP2017114866A5 (enExample)
JP2018516853A5 (enExample)
JP2014534242A5 (enExample)
JP2013538057A5 (enExample)
FI3310812T3 (fi) Anti-her2-vasta-aineita ja käyttömenetelmiä
PE20240218A1 (es) Anticuerpos madurados por afinidad y humanizados para fcrh5
JP2020525032A5 (enExample)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2013198490A5 (enExample)
JP2019533989A5 (ja) 抗pd−1抗体及びその使用
FI3826667T3 (fi) Claudin6 vasta-aineita ja menetelmiä syövän hoitamiseksi
HRP20200390T1 (hr) Monoklonska antitijela protiv humanog antigena starenja b stanica (bcma)
JP2018527919A5 (enExample)
JP2018524001A5 (enExample)
JP2014526898A5 (enExample)
JP2017149720A5 (enExample)
JP2018506961A5 (enExample)
JP2015504421A5 (enExample)
JP2016538832A5 (enExample)
JP2013519364A5 (enExample)